Nielsen B S, Sehested M, Timshel S, Pyke C, Danø K
Finsen Laboratory, University of Copenhagen, Rigshospitalet, Denmark.
Lab Invest. 1996 Jan;74(1):168-77.
Urokinase plasminogen activator (uPA) is a serine proteinase involved in degradation of the extracellular matrix during cancer invasion. uPA is up-regulated in breast cancer, and high levels of uPA in tumor extracts are strongly associated with poor prognosis. Like several other matrix proteinases, uPA is in some types of cancer, including breast cancer, expressed by stromal cells. The present study was undertaken to determine the identity of the uPA-expressing stromal cells in breast cancer tissue. By in situ hybridization, a positive signal for uPA mRNA was in 26 of 28 ductal and four of five lobular carcinomas demonstrated in stromal cells adjacent to nests of cancer cells, whereas only one ductal carcinoma showed a positive reaction in the epithelial component itself. The positive stromal cells were found in both the peripheral and central parts of the tumors. Stromal cells surrounding carcinoma in situ lesions were uPA mRNA positive in a few cases, and no signal was observed in the neighboring nonmalignant tissue. Cell identification was done by immunostaining with Ab to markers for the following cell types: myoepithelial cells, myofibroblasts, smooth muscle cells, macrophages, endothelial cells, and epithelial cells. The only one of these cell types that had a distribution similar to the uPA mRNA-expressing cells was myofibroblasts, recognized as extravascular alpha-smooth muscle actin-positive and cytokeratin-negative cells. On adjacent sections, colocalization was found of cells positive for uPA mRNA and cells positive for alpha-smooth muscle actin and negative for cytokeratin. We concluded that the uPA mRNA-expressing cells are myofibroblasts. The myofibroblasts have previously been found to be abundant in breast cancer tissue. They primarily originate by differentiation of fibroblasts, probably induced by cytokines released from the cancer cells. The present findings suggest that the myofibroblasts, through production of uPA, play an active role in breast cancer invasion.
尿激酶型纤溶酶原激活剂(uPA)是一种丝氨酸蛋白酶,参与癌症侵袭过程中细胞外基质的降解。uPA在乳腺癌中表达上调,肿瘤提取物中高水平的uPA与预后不良密切相关。与其他几种基质蛋白酶一样,uPA在包括乳腺癌在内的某些类型癌症中由基质细胞表达。本研究旨在确定乳腺癌组织中表达uPA的基质细胞的身份。通过原位杂交,在28例导管癌中的26例以及5例小叶癌中的4例中,癌细胞巢相邻的基质细胞中显示出uPA mRNA的阳性信号,而只有1例导管癌在上皮成分本身显示出阳性反应。阳性基质细胞在肿瘤的外周和中央部分均有发现。少数原位癌病变周围的基质细胞uPA mRNA呈阳性,在相邻的非恶性组织中未观察到信号。通过用针对以下细胞类型标志物的抗体进行免疫染色来进行细胞鉴定:肌上皮细胞、肌成纤维细胞、平滑肌细胞、巨噬细胞、内皮细胞和上皮细胞。这些细胞类型中唯一一种分布与表达uPA mRNA的细胞相似的是肌成纤维细胞,其被识别为血管外α平滑肌肌动蛋白阳性且细胞角蛋白阴性的细胞。在相邻切片上,发现uPA mRNA阳性细胞与α平滑肌肌动蛋白阳性且细胞角蛋白阴性的细胞共定位。我们得出结论,表达uPA mRNA的细胞是肌成纤维细胞。先前已发现肌成纤维细胞在乳腺癌组织中大量存在。它们主要起源于成纤维细胞的分化,可能是由癌细胞释放的细胞因子诱导的。目前的研究结果表明,肌成纤维细胞通过产生uPA在乳腺癌侵袭中发挥积极作用。